Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / News / 2011 News

2011 News

All news items from 2011 plus older items from 2009-2010.

Control of Cell Movement with Light Accomplished in Living Organisms

by Susan Lucas last modified Apr 01, 2011 04:47 PM

UNC-developed technique has broad applications in cancer, biomedical research

Control of Cell Movement with Light Accomplished in Living Organisms - Read More…

A Summer of Cycling

A Summer of Cycling

by Susan Lucas last modified Apr 01, 2011 05:17 PM

Local Group Bikes Across the Country to Raise Money for UNC Lineberger

A Summer of Cycling - Read More…

UNC Lineberger Partners to Increase Clinical Trial Participation

by Susan Lucas last modified Apr 01, 2011 01:42 PM

Group Received ASCO 2010 Clinical Trial Participation Award

UNC Lineberger Partners to Increase Clinical Trial Participation - Read More…

DeSimone Accepts Adjunct Appointment at Memorial Sloan-Kettering Cancer Center

by Susan Lucas last modified Apr 01, 2011 01:40 PM

Strategic Partnership to Advance Nanotechnology-Based Diagnosis and Treatment

DeSimone Accepts Adjunct Appointment at Memorial Sloan-Kettering Cancer Center - Read More…

Drug mitigates toxic effects of radiation in mice

by Susan Lucas last modified Mar 09, 2011 03:39 PM

Discovery has potential for cancer patients and disaster victims

Drug mitigates toxic effects of radiation in mice - Read More…

Opinion editorial by James Evans, MD, PhD

by Susan Lucas last modified Apr 01, 2011 01:06 PM

Evans is director of clinical cancer genetics at UNC Lineberger. Article originally published in the June 27, 2010 issue of Newsday.

Opinion editorial by James Evans, MD, PhD - Read More…

Cancer Became a Divining Rod for Campbell Student

Cancer Became a Divining Rod for Campbell Student

by Susan Lucas last modified Mar 31, 2011 05:01 PM

This news story was originally published on June 17, 2010 by Campbell University. Reprinted with permission

Cancer Became a Divining Rod for Campbell Student - Read More…

Unearthing King Tet: Key protein influences stem cell fate

Unearthing King Tet: Key protein influences stem cell fate

by Susan Lucas last modified Mar 31, 2011 04:51 PM

UNC researchers reveal how a protein called Tet1 helps stem cells keep their “stemness” in a paper published in Nature.

Unearthing King Tet: Key protein influences stem cell fate - Read More…

Support for Single Fathers Now Available

by Susan Lucas last modified Mar 09, 2011 03:54 PM

Part of UNC Comprehensive Cancer Support Program

Support for Single Fathers Now Available - Read More…

Sharpless Featured in Current Issue of endeavors

by Susan Lucas last modified Jun 17, 2013 10:58 AM

The article "How Old Are You, Really?" written by Mark Derewicz and published in the Fall 2010 issue of Endeavors magazine features UNC Lineberger member Ned Sharpless, MD. Dr. Sharpless is an associate professor of medicine and genetics and associate director for translational research at UNC Lineberger.

Sharpless Featured in Current Issue of endeavors - Read More…

UNC Scientist Receives NIH Director’s New Innovator Award

UNC Scientist Receives NIH Director’s New Innovator Award

by Susan Lucas last modified Mar 31, 2011 03:25 PM

Project Focuses on Efficient, Low-Cost Genetic Analysis

UNC Scientist Receives NIH Director’s New Innovator Award - Read More…

UNC Lineberger Announces Jessica Breland Comeback Kids Fund

UNC Lineberger Announces Jessica Breland Comeback Kids Fund

by Susan Lucas last modified Nov 06, 2012 11:47 AM

ABC Anchor Robin Roberts Guest of Honor at Kickoff Event

UNC Lineberger Announces Jessica Breland Comeback Kids Fund - Read More…

NCCU and UNC Lineberger Receive NCI Partnership Grant

by Susan Lucas last modified Mar 31, 2011 02:52 PM

$11.9 Million in awards to address cancer disparities

NCCU and UNC Lineberger Receive NCI Partnership Grant - Read More…

inside2.jpg

Toxicity of the anticancer drug CPT-11 is alleviated by inhibiting a specific enzyme (pictured in purple and blue) in human symbiotic gastrointestinal bacteria. Researchers identified compounds (yellow) that target and bind to the enzyme, blocking the reaction that leads to the drug's debilitating side effects. Credit: Bret D. Wallace and Matthew R. Redinbo, UNC-Chapel Hill.

inside2.jpg - Read More…

UNC Team Discovers Promising Target for New Pancreatic Cancer Treatments

by Susan Lucas last modified Aug 10, 2011 12:31 PM

Cell signaling protein may hold key to blocking long-studied genetic mutation

UNC Team Discovers Promising Target for New Pancreatic Cancer Treatments - Read More…

UNC Named LIVESTRONG® Community Impact Project Award Recipient

by Susan Lucas last modified Mar 09, 2011 04:12 PM

Organization will receive The Artist in Residence Program to help people affected by cancer

UNC Named LIVESTRONG® Community Impact Project Award Recipient - Read More…